Literature DB >> 2730379

Duchenne muscular dystrophy manifesting carriers.

P E Barkhaus1, J M Gilchrist.   

Abstract

Seven unrelated women were manifesting carriers of Duchenne muscular dystrophy. A manifesting carrier of Duchenne muscular dystrophy is defined as a female with a history of Duchenne muscular dystrophy in her pedigree who has symptomatic weakness. All were characterized by slowly progressive weakness that began in the second or third decade of life. Asymmetric weakness was present in only three of the seven patients. Serum creatine kinase values were elevated in all patients and none had an electrocardiogram indicating ventricular hypertrophy. The electromyogram and muscle biopsy specimens were reported as myopathic in all patients studied. In the absence of a male relative with Duchenne muscular dystrophy, clinical distinction from cases of autosomal recessive limb girdle muscular dystrophy may not be possible. The development of new techniques in molecular genetics should allow precise identification of manifesting carriers of Duchenne muscular dystrophy in the near future.

Entities:  

Mesh:

Year:  1989        PMID: 2730379     DOI: 10.1001/archneur.1989.00520420093029

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

Authors:  E Pegoraro; R N Schimke; K Arahata; Y Hayashi; H Stern; H Marks; M R Glasberg; J E Carroll; J W Taber; H B Wessel
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

2.  A symptomatic female patient with Duchenne muscular dystrophy diagnosed by dystrophin-staining: a case report.

Authors:  K Shigihara-Yasuda; H Tonoki; Y Goto; K Arahata; N Ishikawa; N Kajii; K Fujieda
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

3.  Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up.

Authors:  Amir Dori; Michela Guglieri; Marianna Scutifero; Luigia Passamano; Antonio Trabacca; Luisa Politano
Journal:  Acta Myol       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.